Newpharma Group SA
100.9 FTEThe score of Newpharma Group shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2024 → 2026: Revenue +630 % Equity +9 % Total assets +10 % Headcount (avg FTE) +141 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Newpharma Group's annual accounts
| 2026 | 2025 | 2024 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €60.9m | ||||
| Net result | 123,707 € | ||||
| Equity | €86.8m | ||||
| Cash | 21,524 € | ||||
| EBITDA | €3.48m | ||||
| Total assets | €109.2m |
Filed annual accounts
- Year ended 31 Mar 2026filed on 21 Sep 2026
- Year ended 31 Mar 2025filed on 25 Sep 2025
- Year ended 31 Mar 2024filed on 19 Sep 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Newpharma Group's financial analysis
- Solvency79.5%sector median: 49.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Newpharma Group
Newpharma Group's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0684.465.652
- VAT number
- BE0684465652
- Peppol
- Registered · 0208:0684465652 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Nov 2017
- Registered office
- 4020 Liège
- Size
- Medium · 100.9 FTE
- Latest accounts
- 2026 · filed on 21 Sep 2026
- Activity
- Activities of head offices (NACE 70100)
Newpharma Group (SA) has been based in Liège since 2017, active in: activities of head offices. For 2026, it reports revenue of €60.9m, a net profit of 123,707 € and equity of €86.8m. With 100.9 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 79.5%, above the median of its sector (49.8%).
Companies similar to Newpharma Group
Companies in the same business, of comparable size and area, outside its group.
- Hyloris Pharmaceuticals Activities of holding companies Liège · balance sheet €101.5m
- Finicoma Business and other management consultancy activities Ghent · balance sheet €83.6m
- MedCare Partners Activities of holding companies Bornem · balance sheet €81.7m
- Nipro Europe Group Companies Activities of holding companies Mechelen · balance sheet €550.4m
- A.forall Group Activities of holding companies Anderlecht · balance sheet €156.6m
- Besins Healthcare Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €110.7m
- Healis Holding Activities of holding companies Geel · balance sheet €53.0m
- Palex Healthcare Group Belgium Activities of holding companies Mechelen · balance sheet €26.8m
Frequently asked questions about Newpharma Group
What is the revenue of Newpharma Group?
According to the 2026 annual accounts filed with the NBB, the revenue of Newpharma Group amounts to 60,938,545 €.
What is the VAT number of Newpharma Group?
In Belgium, the VAT number is the company number prefixed with BE: BE0684465652 for Newpharma Group, if the company is VAT-registered. Its company number (CBE) is 0684.465.652.
Where is the registered office of Newpharma Group?
According to the CBE register, the registered office of Newpharma Group is in 4020 Liège.
What is the equity of Newpharma Group?
At the close of the 2026 financial year, the equity of Newpharma Group amounts to 86,837,159 €, a solvency of 79.5% of total assets.
How many people work at Newpharma Group?
100.9 full-time equivalents on average according to the 2026 social balance sheet.
Who manages Newpharma Group?
The register lists 8 active mandates at Newpharma Group. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Newpharma Group
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →